The identification of optimal ophthalmic solutions for macular defects is a complex issue. Currently, non-surgical treatments such as topical medications are not a standard or proven method for resolving a full-thickness macular hole. While some eye drops can alleviate symptoms related to associated conditions, they do not address the primary structural defect. For instance, lubricating eye drops may provide relief from dryness, which can be exacerbated by other macular degeneration-related issues.
Addressing macular holes primarily involves surgical interventions, specifically vitrectomy. The vitrectomy procedure aims to flatten the macula, which can improve and stabilize vision. Eye drops play an important supportive role post-surgery, and can assist in the healing process, reduce the risk of infection and manage post operative inflammation. The post-operative care is essential for the best possible recovery.